Jeremy Levin

Jeremy Max Levin is the founder of Ovid Therapeutics, Inc., founded in 2014, serving as Executive Chairman.
Current jobs include Executive Chairman & Chief Executive Officer at Ceryvyn Therapeutics Ltd. since 2025, Director at Biotechnology Innovation Organization since 2021, and Advisor at New Rhein Healthcare Investors.
Former jobs include President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd. from 2012 to 2013, Chairman & Chief Executive Officer at Cadus Corp.
from 1992 to 1998, Chief Executive Officer at Physiome Sciences, Inc. from 1998 to 2003, Director at ZymoGenetics, Inc. in 2010, Independent Non-Executive Director at Biocon Ltd. from 2015 to 2020, Director at The Biotechnology Institute, Director at New York Biotechnology Association, Inc., Director at ZappRx, Inc., Independent Director at H.
Lundbeck A, SVP-Strategy, Alliances & Transactions at Bristol Myers Squibb Co. from 2007 to 2012, Global Head-Strategic Alliances at Novartis Institutes for Biomedical Research, Inc. from 2002 to 2007, and President at Medarex, Inc. from 2009 to 2011.
Education includes undergraduate and graduate degrees from the University of Oxford, with the undergraduate degree conferred in 1974, and a doctorate from the University of Cambridge.